Skip to main content
. 2023 May 2;2023(2):22-0378. doi: 10.1530/EDM-22-0378

Table 2.

Hormonal parameters.

Case number PC (µg/dL) ACTH (pg/mL) LNSC (µg/dL) UFC (µg/24 h) 1-mg DST (µg/dL) 8-mg DST ΔPCa % CRH stimulation testb BIPSS (ACTH C/P gradient)c BIPSS (PRL C/P basal gradient) Other hormones and biomarkers
ΔACTH, % ΔPC, % Basal After CRH 17OH, µg/L ADS, µg/dL 5HIIA, mg/24h CgA, ng/mL
Normal range 5–25 5-60 0.0–0.2 20–120 PC < 1.8 0.25–3.90 0.30–2.60 7–8.2 19–98
1 40.5 263 - 4470 37.2 - +43.91 +14.04 1.78 0.97 29.5/12.8 = 2.30 8.26 >10 82.7
2 20 132.6 0.296 1229 - −1 +45.02 +8.83 1.39 1.73 11.8/10.8 = 1.09 5.86 9.6
3 49 75 1.21 838 - - +19.41 +11.5 1.39 1.56 5.5/8.1 = 0.67 5.26 293
4 27.8 139.5 0.063 2227 28.4 +0.6 +10 +18.5 1.02 1.42 - >10
5 52.1 226 - 6246 - - −20 - - -
6 79.6 271.6 - 1500 86.1 - - - - 3302
7 98.1 248.2 - 1860 34.4 −18.89 - - - >10
8 47.1 162.9 - 11,876 54.3 - - - - 89
9 42.4 274.8 1.12 1395 43.3 −36.55 - - - 186
10 62.8 120.1 0.05 2552 27.5 - - - - -
11 49.9 84.6 2.12 - 45.7 −8.61 - - - -
12 97.1 236.7 - 1920 79.4 −13.18 - - - -

aSuppression was considered if ΔPC < −50%; bStimulationwas positive for Cushing’s disease if ΔACTH > 50% and ΔPC >20%; cACTH C/P gradient basal >2 or after stimulation by CRH >3 was positive for Cushing’s disease.

1-mg DST, 1-mg (low-dose) dexamethasone suppression test; 5HIIA, 5 hydroxyindolacetic acid; 8-mg DST, 8-mg (high-dose) dexamethasone suppression test; 17OHP, 17 hydroxyprogesterone; ACTH, adrenocorticotropic hormone; BIPSS, bilateral inferior petrosal sinus sampling; C/P, central/peripheral; CgA, chromogranin A; CRH, corticotropin-releasing hormone; LNSC, late-night salivary cortisol; PC, plasma cortisol; PRL, prolactin; UFC, 24-h urinary free cortisol.